In late 2020, after circulating for almost a year in the human population, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation …

The control of retroviral infection by antiviral factors referred to as restriction factors has
become an exciting area in infectious disease research. TRIM5α has emerged as an important …

Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages
without stimulating innate immunity despite reverse transcription of genomic RNA into double…

Many mammalian species express restriction factors that confer host resistance to retroviral
infection. Here we show that HIV-1 sensitivity to restriction factors is modulated by cyclophilin …

Lentiviruses such as HIV-1 traverse nuclear pore complexes (NPC) and infect terminally
differentiated non-dividing cells, but how they do this is unclear. The cytoplasmic NPC protein …

HIV-1 was recognized as the cause of AIDS in humans in 1984. Despite 30 years of intensive
research, we are still unraveling the molecular details of the host-pathogen interactions …

The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance
human-to-human transmission 1 , 2 . Although much effort has focused on the characterization …

The HIV-1 genome enters cells inside a shell comprised of capsid (CA) protein. Variation in
CA sequence alters HIV-1 infectivity and escape from host restriction factors. However, apart …

The antiretroviral restriction factor TRIM5 has recently emerged as an important mediator of
innate immunity and species-specific inhibition of retroviral replication in mammals. …

During the early stages of infection, the HIV-1 capsid protects viral components from cytosolic
sensors and nucleases such as cGAS and TREX, respectively, while allowing access to …